CARDINAL HEALTH- sodium fluoride paste, dentifrice USA - engelska - NLM (National Library of Medicine)

cardinal health- sodium fluoride paste, dentifrice

cardinal health 200, llc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - anticavity toothpaste aids in the prevention of dental cavities

TOPROL XL- metoprolol succinate tablet, extended release USA - engelska - NLM (National Library of Medicine)

toprol xl- metoprolol succinate tablet, extended release

cardinal health - metoprolol succinate (unii: th25pd4ccb) (metoprolol - unii:geb06nhm23) - metoprolol tartrate 25 mg - toprol-xl is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE- lidocaine hydrochloride anhydrous and epinephrine injection, solution USA - engelska - NLM (National Library of Medicine)

lidocaine hydrochloride and epinephrine- lidocaine hydrochloride anhydrous and epinephrine injection, solution

cardinal health - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride and epinephrine injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

MISOPROSTOL tablet USA - engelska - NLM (National Library of Medicine)

misoprostol tablet

cardinal health - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 200 ug - misoprostol is indicated for reducing the risk of nsaid (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. misoprostol tablet has not been shown to reduce the risk of duodenal ulcers in patients taking nsaids. misoprostol tablets should be taken for the duration of nsaid therapy. misoprostol tablets has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months’ duration. it had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with nsaid use. see boxed warnings . misoprostol tablets should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (nsaids). misoprostol tablets should not be taken by anyone with a history of all

PRISTIQ EXTENDED-RELEASE- desvenlafaxine succinate tablet, extended release USA - engelska - NLM (National Library of Medicine)

pristiq extended-release- desvenlafaxine succinate tablet, extended release

cardinal health - desvenlafaxine succinate (unii: zb22enf0xr) (desvenlafaxine - unii:ng99554anw) - desvenlafaxine 50 mg - pristiq, a serotonin and norepinephrine reuptake inhibitor (snri), is indicated for the treatment of major depressive disorder (mdd) [see clinical studies (14) and dosage and administration (2.1)] . the efficacy of pristiq has been established in four short-term (8-week, placebo-controlled studies) and two maintenance studies in adult outpatients who met dsm-iv criteria for major depressive disorder. pregnancy category c risk summary there are no adequate and well-controlled studies of pristiq in pregnant women. in reproductive developmental studies in rats and rabbits with desvenlafaxine succinate, evidence of teratogenicity was not observed at doses up to 30 times a human dose of 100 mg per day (on a mg/m2 basis) in rats, and up to 15 times a human dose of 100 mg per day (on a mg/m2 basis) in rabbits. an increase in rat pup deaths was seen during the first 4 days of lactation when dosing occurred during gestation and lactation, at doses greater than 10 times a human dose of 100 mg per day (on a mg/m2 bas

METHOCARBAMOL tablet USA - engelska - NLM (National Library of Medicine)

methocarbamol tablet

cardinal health - methocarbamol (unii: 125od7737x) (methocarbamol - unii:125od7737x) - methocarbamol 750 mg - methocarbamol tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. methocarbamol does not directly relax tense skeletal muscles in man. methocarbamol tablets are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

CLONIDINE HYDROCHLORIDE- clonidine hydrochloride tablet USA - engelska - NLM (National Library of Medicine)

clonidine hydrochloride- clonidine hydrochloride tablet

cardinal health - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride tablets are indicated in the treatment of hypertension. clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents. clonidine hydrochloride tablets should not be used in patients with known hypersensitivity to clonidine (see precautions).

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE- lidocaine hydrochloride anhydrous and epinephrine injection, solution USA - engelska - NLM (National Library of Medicine)

lidocaine hydrochloride and epinephrine- lidocaine hydrochloride anhydrous and epinephrine injection, solution

cardinal health 107, llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride and epinephrine injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

OMEPRAZOLE- omeprazole capsule, delayed release USA - engelska - NLM (National Library of Medicine)

omeprazole- omeprazole capsule, delayed release

cardinal health - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within 4 weeks. some patients may require an additional 4 weeks of therapy. omeprazole delayed-release capsules, in combination with clarithromycin and amoxicillin, are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to one year history) to eradicate h. pylori in adults. omeprazole delayed-release capsules, in combination with clarithromycin are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see clinical studies (14.1) and dosage and administration (2)]. among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin are more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. in pati

CARDINAL HEALTH SANITIZER- alcohol aerosol, foam USA - engelska - NLM (National Library of Medicine)

cardinal health sanitizer- alcohol aerosol, foam

cardinal health - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - place enough product in your palm to thoroughly cover your hands - rub hands together briskly until dry - children under 6 years of age should be supervised when using this product antimicrobial